Epitalon (EPIT)

Sleep Preclinical

Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026

TL;DR — Epitalon at a Glance

Epitalon (EPIT) is a sleep peptide, at the preclinical stage in the published literature. Tetrapeptide that regulates melatonin production and circadian rhythm through pineal gland stimulation.

Tetrapeptide that regulates melatonin production and circadian rhythm through pineal gland stimulation.

Key Data

Research StatusPreclinical
Half-LifeUnknown
AdministrationSubcutaneous injection
Doses Reported in Published Studies5-10 mg daily

Mechanism of Action

Stimulates pineal gland, normalizes melatonin cycles, activates telomerase.

Reported Benefits

Frequently Asked Questions

What is Epitalon?

Tetrapeptide that regulates melatonin production and circadian rhythm through pineal gland stimulation.

How does Epitalon work?

Stimulates pineal gland, normalizes melatonin cycles, activates telomerase.

What is the research status of Epitalon?

Epitalon is at the following stage in the published literature: Preclinical. All information is for research and educational purposes only.

What is the half-life of Epitalon?

Reported half-life: Unknown.

How is Epitalon administered in research?

Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.

Educational content, not medical advice. Effects described are drawn from cited research in study subjects.

← All Peptides Dosing Calculator The Dispatch Home